Almirall
The Director, External Innovation & Asset Evaluation leads the end-to-end external opportunity funnel at a strategic level, translating portfolio priorities into focused search strategies and decision-ready asset evaluations. This role provides senior scientific and strategic leadership, integrating cross-functional inputs to support high-quality portfolio decisions and long-term business objectives. The position involves leading early asset evaluations, coordinating due diligence efforts, and building senior external networks to anticipate emerging opportunities.
Almirall is a global pharmaceutical company dedicated to medical dermatology, collaborating with leading scientists, healthcare professionals and patients.
Headquarters
San Francisco, CA
Company Size
201-500 employees
Founded
2018
Industry
Technology
Glassdoor Rating
4.2 / 5
Sarah Johnson
Chief Executive Officer
Michael Chen
Chief Technology Officer
Emily Williams
VP of Engineering
David Rodriguez
VP of Product
Jessica Thompson
Chief Financial Officer
Andrew Park
VP of Sales
View leadership team, funding history,
and employee contacts for Almirall.
Almirall didn’t post a salary, so this is our estimate from similar listings.
Senior Director, Oncology Search & Evaluation
BioLife Plasma Services
Director, External Innovation
Acadia Pharmaceuticals Inc.
Head of Search & Evaluation, External Innovation, China
AbbVie
Search and Evaluation Director, Respiratory & Immunology
AstraZeneca
Senior Director, Search & Evaluation
1080030P
Search and Evaluation Director, Respiratory & Immunology
American Association of Physicists in Medicine